Since the suppression of miRNA-122-5p significantly reduces AFP level and the proliferation in AFP-producing gastric cancer (AFPGC), miRNA-122-5p has been regarded as a potential therapeutic target in AFPGC [56]. The gene discussed is AFP; the disease is gastric cancer.